FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lutz Froelich

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Lies Clerx; Remko de Jong; Lutz Froelich; Harald Hampel; Dirk L Knol; Pablo Lapuerta; Lennart Minthon; Flavio Nobili; Daniel Rueckert; Philip scheltens; Hilkka Soininen; Magdalini Tsolaki; Laura A van de Pol; Ineke A van Rossum; Ronald van Schijndel; Frans Verhey; Pauline Aalten; Frederik Barkhof; Martina Bocchetta; Leah Burns; Lars-Olaf Wahlund; Robin Wolz; Pieter Jelle Visser
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.
Angelique P A Vermeiren; Pieter-Jelle Visser; Lars-Olof Wahlund; Gordon K Wilcock; Maurice P Zeegers; Hans Bosma; Lyzel S Elias-Sonnenschein; Michael Ewers; Giovanni B Frisoni; Lutz Froelich; Caroline Graff; Harald Hampel; Roy W Jones; Patrick G Kehoe; HERMINE LENOIR; Lennart Minthon; Flavio M Nobili; Marcel Olde Rikkert; Anne-Sophie Rigaud; Philip scheltens; Hilkka Soininen; Luiza Spiru; Magda Tsolaki; Bruno Vellas; Frans R J Verhey
The Association Between APOE ε4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study.
Alexander Kurz; Angelika Thöne-Otto; Stefan Wagenpfeil; Barbara Cramer; Silvia Egert; Lutz Froelich; Hermann-Josef Gertz; Victoria Kehl; Katja Werheid
CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lutz Froelich (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lies Clerx; Remko de Jong; Lutz Froelich; Harald Hampel; Dirk L Knol; Pablo Lapuerta; Lennart Minthon; Flavio Nobili; Daniel Rueckert; Philip scheltens; Hilkka Soininen; Magdalini Tsolaki; Laura A van de Pol; Ineke A van Rossum; Ronald van Schijndel; Frans Verhey; Pauline Aalten; Frederik Barkhof; Martina Bocchetta; Leah Burns; Lars-Olaf Wahlund; Robin Wolz; Pieter Jelle Visser
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.
Neurobiology of aging 2013;34(8):2003-13.
2013: Angelique P A Vermeiren; Pieter-Jelle Visser; Lars-Olof Wahlund; Gordon K Wilcock; Maurice P Zeegers; Hans Bosma; Lyzel S Elias-Sonnenschein; Michael Ewers; Giovanni B Frisoni; Lutz Froelich; Caroline Graff; Harald Hampel; Roy W Jones; Patrick G Kehoe; HERMINE LENOIR; Lennart Minthon; Flavio M Nobili; Marcel Olde Rikkert; Anne-Sophie Rigaud; Philip scheltens; Hilkka Soininen; Luiza Spiru; Magda Tsolaki; Bruno Vellas; Frans R J Verhey
The Association Between APOE ε4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study.
Journal of Alzheimer's disease : JAD 2013;35(2):241-6.
2012: Alexander Kurz; Angelika Thöne-Otto; Stefan Wagenpfeil; Barbara Cramer; Silvia Egert; Lutz Froelich; Hermann-Josef Gertz; Victoria Kehl; Katja Werheid
CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial.
Alzheimer disease and associated disorders 2012;26(3):246-53.
2012: L Hausner; K Jekel; M Richter; M Damian; Lutz Froelich
[Attitudes toward dementia management in Germany - Data from the IMPACT survey (Important Perspectives on Alzheimer's Care and Treatment)].
Deutsche medizinische Wochenschrift (1946) 2012;137(25-26):1351-5.
2012: Heidi I L Jacobs; Jelle Jolles; Lennart Minthon; Flavio Nobili; Panagiota Papapostolou; Philip scheltens; Hilkka Soininen; Frans E S Tan; Magda Tsolaki; Martin P J Van Boxtel; Laura A van de Pol; Giovanni B Frisoni; Lutz Froelich; Harald Hampel; Pieter Jelle Visser; Lars-Olof Wahlund; Frans R J Verhey
Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent.
Neurobiology of aging 2012;33(1):201.e1-8.
2011: Frank Jessen; Johannes Kornhuber; Thomas Kucinski; Piotr Lewczuk; Wolfgang Maier; Oliver Peters; Julius Popp; Frank Träber; Sönke Arlt; Wolfgang Block; Gabriele Ende; Lutz Froelich; Okan Gür; Thilo Hammen; Jens Wiltfang
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia.
Journal of Alzheimer's disease : JAD 2011;27(2):393-9.
2010: J Lindesay; R Bullock; H Daniels; M Emre; hans förstl; Lutz Froelich; T Gabryelewicz; P Martínez-Lage; A U Monsch; M Tsolaki; T van Laar
Turning principles into practice in Alzheimer's disease.
International journal of clinical practice 2010;64(9):1198-209.
2010: Murat Emre; Roberto Bernabei; Rafael Blesa; Roger Bullock; Luis Cunha; Hugo Daniëls; Edward Dziadulewicz; hans förstl; Lutz Froelich; Tomasz Gabryelewicz; Oleg Levin; James Lindesay; Pablo Martínez-Lage; Andreas Monsch; Magda Tsolaki; Teus van Laar
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
CNS neuroscience & therapeutics 2010;16(4):246-53.
2010: Stefan J Teipel; Michael Ewers; Stefanie Wolf; Frank Jessen; Heike Kölsch; Sönke Arlt; Christian Luckhaus; Peter Schönknecht; Klaus Schmidtke; Isabella Heuser; Lutz Froelich; Gabriele Ende; Johannes Pantel; Jens Wiltfang; Fabian Rakebrandt; Oliver Peters; Christine Born; Johannes Kornhuber; Harald Hampel
Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
Psychiatry research 2010;182(3):244-50.
2010: Bengt Winblad; Ezio Giacobini; Lutz Froelich; Lawrence T Friedhoff; Gosse Bruinsma; Robert E Becker; Nigel H Greig
Phenserine efficacy in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;22(4):1201-8.
2010: Lucrezia Hausner; Lutz Froelich; Virginie Gardette; Emma Reynish; Pierre-Jean Ousset; Sandrine Andrieu; Bruno Vellas
Regional variation on the presentation of Alzheimer's disease patients in memory clinics within Europe: data from the ICTUS study.
Journal of Alzheimer's disease : JAD 2010;21(1):155-65.
2009: Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; D M A Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick C Fox; Martin N Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Froelich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gillian Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher Shaw; Magda Tsolaki; Andrew Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Nature genetics 2009;41(10):1088-93.
2009: Laura A van de Pol; Frans Verhey; Giovanni B Frisoni; M Tsolaki; P Papapostolou; F Nobili; Lars-Olof Wahlund; L Minthon; Lutz Froelich; Harald Hampel; Hilkka Soininen; Dirk L Knol; Frederik Barkhof; Philip scheltens; Pieter Jelle Visser
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.
Journal of neurology, neurosurgery, and psychiatry 2009;80(10):1069-74.
2009: Harald Hampel; Michael Ewers; Katharina Bürger; Peter Annas; Anette Mörtberg; Anna Bogstedt; Lutz Froelich; Johannes Schröder; Peter Schönknecht; Matthias W Riepe; Inga Kraft; Thomas Gasser; Thomas Leyhe; Hans-Jürgen Möller; Alexander Kurz; Hans Basun
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
The Journal of clinical psychiatry 2009;70(6):922-31.
2009: Frank Jessen; O Gür; Wolfgang Block; G Ende; Lutz Froelich; T Hammen; Jens Wiltfang; Thomas Kucinski; H Jahn; Reinhard Heun; Wolfgang Maier; Heike Kölsch; J Kornhuber; Frank Träber
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
Neurology 2009;72(20):1735-40.
2009: Heike Kölsch; Frank Jessen; Jens Wiltfang; Piotr Lewczuk; Martin Dichgans; Stefan J Teipel; Johannes Kornhuber; Lutz Froelich; Isabella Heuser; Oliver Peters; Birgitt Wiese; Hanna Kaduszkiewicz; Hendrik van den Bussche; Michael Hüll; Alexander Kurz; Eckhart Rüther; Fritz A Henn; Wolfgang Maier
Association of SORL1 gene variants with Alzheimer's disease.
Brain research 2009;1264():1-6.
2009: George T Grossberg; Carl Sadowsky; Hans Fröstl; Lutz Froelich; Jennifer Nagel; Sibel Tekin; Stefanie Zechner; Jacqueline Ros; Jean-Marc Orgogozo
Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension.
Alzheimer disease and associated disorders 2009;23(2):158-64.
2009: Kaj Blennow; Geert De Meyer; Oskar Hansson; L Minthon; Anders Wallin; Henrik Zetterberg; P Lewczuk; hugo vanderstichele; E Vanmechelen; J Kornhuber; J Wiltfang; I Heuser; W Maier; C Luckhaus; E Rüther; M Hüll; H Jahn; H J Gertz; Lutz Froelich; Harald Hampel; R Pernetzki
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.
The journal of nutrition, health & aging 2009;13(3):205-8.
2009: Matthias W Riepe; Thomas Mittendorf; hans förstl; Lutz Froelich; Martin Haupt; Reiner Leidl; Christoph Vauth; Matthias Graf von der Schulenburg
Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.
BMC neurology 2009;9():47.
2009: hans förstl; H Bickel; Lutz Froelich; Hermann-Josef Gertz; hans gutzmann; R Hörr; J Pantel; R Schmidt; P Schönknecht; K Ulm; K Werheid
[MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy].
Deutsche medizinische Wochenschrift (1946) 2009;134(1-2):39-44.
2009: Alistair Burns; Roberto Bernabei; Roger Bullock; Alfonso J Cruz Jentoft; Lutz Froelich; Christoph Hock; Minna Raivio; Eric Triau; Maurits Vandewoude; Anders Wimo; Elizabeth Came; Bart Van Baelen; Gerry L Hammond; Joop Van Oene; Susanne Schwalen
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
Lancet neurology 2009;8(1):39-47.
2008: Heike Kölsch; Frank Jessen; Jens Wiltfang; Piotr Lewczuk; Martin Dichgans; Johannes Kornhuber; Lutz Froelich; Isabella Heuser; Oliver Peters; Jörg B Schulz; Sibylle G Schwab; Wolfgang Maier
Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.
Neuroscience letters 2008;440(1):68-71.
2007: Sabine Krause; T Göhringer; Maggie C Walter; Benedikt Schoser; Peter Reilich; Jennifer Linn; Gabriele Pöpperl; Lutz Froelich; Frank Hentschel; Hanns Lochmüller; Adrian Danek
Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein.
Clinical neuropathology 2007;26(5):232-40.
2007: Bengt Winblad; G Grossberg; Lutz Froelich; Martin R Farlow; S Zechner; J Nagel; Roger Lane
IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
Neurology 2007;69(4 Suppl 1):S14-22.
2007: S Schwarz; Lutz Froelich; J-P Striebel; M G Hennerici
[The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
Deutsche medizinische Wochenschrift (1946) 2007;132(3):108-12.
2006: Lutz Froelich
[Patient-relevant end points in Alzheimer's disease].
Deutsche medizinische Wochenschrift (1946) 2006;131(19 Suppl 1):S31-4.
2005: Marcel G M Olde Rikkert; S Lauque; Lutz Froelich; Bruno Vellas; Wim Dekkers
The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(3):212-7.
2004: Richard Dodel; Yansheng Du; Candan Depboylu; Harald Hampel; Lutz Froelich; A Haag; U Hemmeter; S Paulsen; Stefan J Teipel; Sylvia Brettschneider; Annika Spottke; C Nölker; Hans-Jürgen Möller; X Wei; Martin R Farlow; Norbert Sommer; Wolfgang H Oertel
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(10):1472-4.
2001: Daniela Hubl; Horst Kleinlogel; Lutz Froelich; Thomas Weinandi; Konrad Maurer; W Holstein; J Czekalla; Thomas Dierks
Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine.
Psychopharmacology 2001;158(3):281-8.
1999: Hans J Markowitsch; Josef Kessler; M O Russ; Lutz Froelich; B Schneider; K Maurer
Mnestic block syndrome.
Cortex; a journal devoted to the study of the nervous system and behavior 1999;35(2):219-30.
1999: Hans-Gert Bernstein; Siegfried Ansorge; Peter Riederer; M Reiser; Lutz Froelich; Bernhard Bogerts
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques.
Neuroscience letters 1999;263(2-3):161-4.
1997: T J Müller; J Thome; Roberta Chiaramonti; T Dierks; K Maurer; Andreas J Fallgatter; Lutz Froelich; M Scheubeck; Werner Strik
A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease.
European archives of psychiatry and clinical neuroscience 1997;247(5):259-63.
1995: S Rahner-Welsch; Lutz Froelich; S Stoll; Siegfried Hoyer
Decline and preservation of reversal learning abilities and acquisition in the course of senescence.
Neuroscience letters 1995;194(1-2):121-3.
1987: Lutz Froelich; G Németh; S Hoyer
Meeting Report: Dementia and stroke: biology of the aging brain.
Neurobiology of aging 1987;8(2):179-84.
1980: Siegfried Hoyer; Lutz Froelich; M Hof; B Volk
First results on the effect of vincristine on brain glucose and energy metabolism in rats.
Mechanisms of ageing and development 1980;14(1-2):223-31.